January is Cervical Cancer Awareness Month and a reminder that the most important thing you can do to prevent cervical cancer is to start screening at the age of 21. The American Cancer Society estimated that about 13,800 new cases of invasive cervical cancer would be diagnosed and about 4,290 women would die in the […]
Tag Archives: GenPath
Press Release
OPKO Health’s BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
01
Sep
Sep
ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples. OnkoSight AdvancedNGS testing provides targeted gene content that is aligned with the latest […]
28
Apr
Apr
Sexually transmitted infections or STIs, also referred to as sexually transmitted diseases or STDs, are common in men and women. April is STD/STI Awareness Month, so there is no time like the present to talk with your sexual partner(s) and get tested. Did You Know? There are approximately 20 million new STI cases each year […]
17
May
May
BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).